Atrás
Rango del Día
$199.67
$214.29
Rango de 52 Semanas
$93.58
$227.92
Volumen
255,600
Promedio 50D / 200D
$197.85
/
$172.55
Cierre Anterior
$204.81
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 32.1 | 0.4 |
| P/B | 3.9 | 2.9 |
| ROE % | 13.5 | 3.8 |
| Net Margin % | 46.4 | 3.9 |
| Rev Growth 5Y % | 2.6 | 10.0 |
| D/E | 0.4 | 0.2 |
Puntos Clave
Revenue grew 2.64% annually over 5 years — modest growth
ROE of 13.47% — decent returns on equity
Net margin of 46.42% shows strong profitability
Debt/Equity of 0.44 — conservative balance sheet
Generating 48.91M in free cash flow
P/E of 32.10 — premium valuation
Crecimiento
Revenue Growth (5Y)
2.64%
Revenue (1Y)60.40%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
13.47%
ROIC2.41%
Net Margin46.42%
Op. Margin17.61%
Seguridad
Debt / Equity
0.44
Current Ratio22.23
Interest Coverage0.00
Valoración
P/E Ratio
32.10
P/B Ratio3.93
EV/EBITDA90.51
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60.40% | Revenue Growth (3Y) | 42.88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 54.48% |
| Revenue Growth (5Y) | 2.64% | Earnings Growth (5Y) | 21.48% |
| Profitability | |||
| Revenue (TTM) | 268.09M | Net Income (TTM) | 124.45M |
| ROE | 13.47% | ROA | 7.97% |
| Gross Margin | 97.54% | Operating Margin | 17.61% |
| Net Margin | 46.42% | Free Cash Flow (TTM) | 48.91M |
| ROIC | 2.41% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.44 | Current Ratio | 22.23 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 32.10 | P/B Ratio | 3.93 |
| P/S Ratio | 14.90 | PEG Ratio | -0.01 |
| EV/EBITDA | 90.51 | Dividend Yield | 0.00% |
| Market Cap | 4.00B | Enterprise Value | 4.27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 268.09M | 167.13M | 131.31M | 196.25M | 241.54M |
| Net Income | 124.45M | -4.03M | 52.15M | -33.36M | 57.14M |
| EPS (Diluted) | 6.13 | -0.22 | 2.94 | -1.98 | 3.34 |
| Gross Profit | 261.50M | 156.06M | 96.27M | 143.42M | 179.37M |
| Operating Income | 47.20M | -22.61M | 11.94M | 3.04M | 103.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.56B | 941.77M | 787.22M | 762.67M | 1.30B |
| Total Liabilities | 543.43M | 111.34M | 86.30M | 165.18M | 476.43M |
| Shareholders' Equity | 1.02B | 830.44M | 700.91M | 597.49M | 821.16M |
| Total Debt | 451.49M | 7.11M | 6.17M | 87.75M | 324.39M |
| Cash & Equivalents | 174.93M | 72.31M | 22.95M | 45.01M | 19.52M |
| Current Assets | 832.27M | 331.56M | 237.43M | 263.60M | 464.75M |
| Current Liabilities | 37.45M | 37.11M | 16.78M | 98.81M | 41.67M |